Moel M, Harinath G, Lee V et al., Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results, Aging 17(4):908–936 (2025) (trial run by a company selling the drug)

https://www.aging-us.com/article/206235/text

Authors. Moel M, Harinath G, Lee V et al

Venue. Aging (trial run by a company selling the drug)

How the Institute flags it

frontier 2 times

Cited on 2 pages

• Cellular Rejuvenation
• Longevity Therapies